Position in ADMA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,221,673
-$296,905 QoQ
Shares Held
2,415,971
+6.1% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. ADMA ranks #78 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ADMA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,221,673 | 2,415,971 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $20,518,578 | 2,277,312 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $41,348,070 | 2,266,890 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $34,609,032 | 2,360,780 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $44,492,508 | 2,443,301 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $51,479,956 | 2,594,756 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $44,162,534 | 2,575,075 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $48,569,462 | 2,429,688 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $23,184,736 | 2,073,769 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,943,575 | 2,112,663 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,935,112 | 2,198,034 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,811,390 | 2,181,953 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,986,442 | 2,164,348 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,110,804 | 1,846,165 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,420,352 | 1,654,730 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,849,741 | 1,584,256 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,174,527 | 1,603,297 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $666,584 | 364,254 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $515,227 | 365,410 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $316,862 | 280,410 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $473,847 | 296,155 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,395,654 | 792,986 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,657,837 | 850,174 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,995,225 | 834,823 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,468,509 | 842,495 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $2,462,436 | 855,013 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||